Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01670006
Other study ID # CAM5397
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 2012
Est. completion date February 2016

Study information

Verified date August 2022
Source Cochlear
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this feasibility study is to obtain preliminary safety and efficacy data associated with cochlear implantation in individuals with severe to profound sensorineural hearing loss contralateral to an ear with normal, or near-normal, hearing. The hypothesis is that restoration of hearing in the deafened ear will result in improved speech perception in the treated ear and advantages related to restoration of hearing to both ears.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date February 2016
Est. primary completion date April 2015
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Ability to provide informed consent. 2. Eighteen years-of-age or older at the time of implantation. 3. Presence of single-sided deafness as follows: 1. Poorer ear (ear to be implanted): - severe to profound sensorineural hearing loss, defined as pure-tone thresholds 80 dB HL or greater for the frequencies 500, 1000, 2000, 3000, and 4000 Hz. - Monosyllabic word understanding, as measured using the CNC Word Test at 60 dBA under earphones, less than or equal to 10%. 2. Better ear (contralateral ear): - Normal or near-normal hearing, defined as pure-tone thresholds no poorer than 30 dB HL at 250, 500, 1000, 2000, and 3000 Hz and no poorer than 40 dB HL at 4000 Hz. - Monosyllabic word understanding, as measured using the CNC Word Test at 60 dBA under earphones, of greater than or equal to 90%. 4. Duration of severe to profound sensorineural hearing loss of at least 6 months (to ensure stability of hearing loss) but no greater than 10 years. 5. English spoken as a primary language. Exclusion Criteria: 1. Alleviation of tinnitus as the stated primary or sole motivation for seeking implantation by the subject and/or investigator. 2. Actively using an implantable device in the poorer ear. 3. Onset of severe to profound hearing loss < 6 years-of-age. 4. Evidence of active middle-ear pathology based on otologic examination and/or immittance testing. 5. Medical or psychological conditions that contraindicate undergoing surgery. 6. Ossification or any other cochlear anomaly at the implant ear that might prevent complete insertion of the electrode array. 7. Hearing loss of neural or central origin, including auditory neuropathy. 8. Unrealistic expectations on the part of the subject regarding the possible benefits, risks, and limitations inherent to the surgical procedure and prosthetic device. 9. Unwillingness and/or inability of the candidate to comply with all investigational requirements including, but not limited to, study protocol and surgical procedure, as determined by the investigator.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Cochlear Nucleus Cochlear Implant System


Locations

Country Name City State
United States New York University Medical Center New York New York

Sponsors (1)

Lead Sponsor Collaborator
Cochlear

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of Subjects With Adverse Events Device and procedure-related anticipated and unanticipated aderse events. 12 months
Secondary Hearing in Noise Test (HINT)Score To access speech perception performance using Hearing in noise test sentences in noise was measured at 12 months post activation. Recorded HINT sentences were presented to participants at 60dBA pre-operatively and 12 months post activation. Resultant score is percentage of words repeated correctly. Possible scores ranges from 0% to 100% correctly repeated. Higher percentage score means better outcome. 12 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT01933386 - Evaluation of Benefit for Treatment of Single Sided Deafness (SSD) Between Two Bone Conduction Prosthetic Devices; Osseointegrated Implant Versus Maxilla Anchored Removable Oral Appliance ("SoundBite") Phase 4
Active, not recruiting NCT01445977 - SoundBite Hearing System Long Term Multi Site Patient Use Study N/A
Recruiting NCT01807559 - SoundBite Hearing System 24 Month Multi Site Patient Use Study N/A
Recruiting NCT05775367 - Cochlear Implants in Young Children With SSD N/A
Recruiting NCT03327194 - Use of ADHEAR, a Non-Implantable Bone Conduction Hearing System, in Children With Single Sided Deafness and/or Conductive Hearing Loss N/A
Completed NCT02064478 - Clinical Survey of Oticon Medical Ponto Implants and a Surgical Technique With Tissue Preservation N/A
Completed NCT02966366 - Tinnitus Treatment With Cochlear Implant in Single Sided Deafness N/A